|Strength||10, 20, 50 mg|
|Packaging||Packed in strips|
What is Natdac?
Natdac contains the active ingredient Daclatasvir. Daclatasvir is used with other antiviral medicines in the treatment chronic hepatitis C infection of genotype 1 or genotype 3 in adults. Natdac must be taken in combination with sofosbuvir, or with sofosbuvir and ribavirin. It must not be taken by itself.
How is Natdac used?
For most patients, one tablet of Daclahelp will be taken daily for a period of 12 weeks. Your doctor may have prescribed you a different dosage and/or a different treatment period. Follow the instructions given to you by your doctor, including any information about how to take Daclatasvir with sofosbuvir and/or ribavirin.
Warnings : Do not take Daclatasvir without taking at least one other antiviral medicine. Sofobuvir should alway sbe taken in conjuction, and for some patients ribavirin will also be necessary. Make sure you are aware of the safety information for all of these medicines.
Some pre-existing conditions can affect daclatasvir, or be affected by taking daclatasvir. Before you start taking Daclatasvir, make sure your doctor knows :